Page last updated: 2024-11-06

mitomycin and Aortic Diseases

mitomycin has been researched along with Aortic Diseases in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Aortic Diseases: Pathological processes involving any part of the AORTA.

Research Excerpts

ExcerptRelevanceReference
"Mitomycin C (MMc) is an antibiotic that exerts a potent antiproliferative effect in tumor cells."1.33Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries. ( Azam, MA; Durante, W; Ensenat, D; Granada, JF; Kaluza, GL; Keswani, AN; Liu, XM; Peyton, KJ; Raizner, AE; Wang, H, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Granada, JF1
Ensenat, D1
Keswani, AN1
Kaluza, GL1
Raizner, AE1
Liu, XM1
Peyton, KJ1
Azam, MA1
Wang, H1
Durante, W1

Other Studies

1 other study available for mitomycin and Aortic Diseases

ArticleYear
Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:11

    Topics: Angioplasty, Balloon; Animals; Antibiotics, Antineoplastic; Aorta, Thoracic; Aortic Diseases; Cell D

2005